Robert Thomas Freeman Sells 39,320 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 39,320 shares of the stock in a transaction that occurred on Tuesday, October 8th. The shares were sold at an average price of $12.04, for a total transaction of $473,412.80. Following the sale, the chief financial officer now owns 194,609 shares in the company, valued at approximately $2,343,092.36. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Robert Thomas Freeman also recently made the following trade(s):

• On Tuesday, October 1st, Robert Thomas Freeman sold 21,375 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.66, for a total transaction of $227,857.50.
• On Friday, September 13th, Robert Thomas Freeman sold 14,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.00, for a total transaction of $174,000.00.
• On Wednesday, September 11th, Robert Thomas Freeman sold 8,561 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total transaction of $85,695.61.
• On Wednesday, September 4th, Robert Thomas Freeman sold 1,650 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.00, for a total transaction of $16,500.00.
• On Friday, July 19th, Robert Thomas Freeman sold 38,858 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.01, for a total transaction of $388,968.58.
• On Wednesday, July 17th, Robert Thomas Freeman sold 22,100 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.00, for a total transaction of $221,000.00.

Alignment Healthcare Stock Up 1.2 %

ALHC opened at $11.45 on Friday. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.70. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $12.36. The company has a market capitalization of $2.19 billion, a PE ratio of -13.96 and a beta of 1.47. The firm’s 50 day simple moving average is $10.03 and its two-hundred day simple moving average is $8.11.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, August 1st. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.01. The firm had revenue of $681.29 million for the quarter, compared to the consensus estimate of $637.66 million. Alignment Healthcare had a negative net margin of 6.85% and a negative return on equity of 101.10%. The company’s revenue was up 47.3% on a year-over-year basis. During the same period last year, the firm earned ($0.15) EPS. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post -0.67 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Barclays raised their target price on shares of Alignment Healthcare from $4.50 to $7.00 and gave the stock an “underweight” rating in a report on Monday, August 5th. Stifel Nicolaus raised their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a report on Friday, July 26th. Robert W. Baird raised their target price on shares of Alignment Healthcare from $10.00 to $11.00 and gave the stock an “outperform” rating in a report on Wednesday, August 14th. Piper Sandler restated an “overweight” rating and issued a $10.00 target price (up previously from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. Finally, KeyCorp initiated coverage on shares of Alignment Healthcare in a report on Friday. They issued a “sector weight” rating on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $9.83.

Institutional Trading of Alignment Healthcare

Institutional investors and hedge funds have recently modified their holdings of the company. Virtu Financial LLC bought a new stake in shares of Alignment Healthcare during the 1st quarter valued at $57,000. Principal Financial Group Inc. bought a new stake in shares of Alignment Healthcare during the 1st quarter valued at $57,000. Creative Planning raised its position in shares of Alignment Healthcare by 20.0% during the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after purchasing an additional 2,072 shares during the period. Mackenzie Financial Corp raised its position in shares of Alignment Healthcare by 110.0% during the 2nd quarter. Mackenzie Financial Corp now owns 36,526 shares of the company’s stock valued at $286,000 after purchasing an additional 19,129 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Alignment Healthcare by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 39,570 shares of the company’s stock valued at $196,000 after purchasing an additional 3,334 shares during the period. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.